This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
|02/21/17||Quest Diagnostics Declares Quarterly Cash Dividend|
|MADISON, N.J., Feb. 21, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.45 per share, payable on April 19, 2017 to shareholders of record of Quest Diagnostics common stock on April 5, 2017.
About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from th... |
|02/16/17||Quest Diagnostics: Harvard Pilgrim Health Care Partners with Physicians to Close Costly Gaps in Care|
|Physicians to use health analytics technology Data Diagnostics® from Quest Diagnostics and Inovalon to help improve patient care and financial performance
MADISON, N.J., Feb. 16, 2017 /PRNewswire/ -- Harvard Pilgrim Health Care now offers physicians Data Diagnostics®, a point-of-care health analytics technology from Quest Diagnostics (NYSE: DGX) and Inovalon (NASDAQ: INOV) that is designed to help close costly gaps in care and improve health outcomes.
|02/16/17||Quest Diagnostics Named One of 2017 "World's Most Admired Companies" by Fortune Magazine|
|MADISON, N.J., Feb. 16, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been named one of the "World's Most Admired Companies" for 2017 by Fortune.
The annual survey designated Quest Diagnostics as one of only six companies in the "Health Care: Pharmacy and Other Services" industry to attain Most Admired status, and the only diagnostic information services compan... |
|02/15/17||Quest Diagnostics and PeaceHealth to Increase Access to Innovative, High-Value Laboratory Services in the Pacific Northwest|
|Quest to acquire PeaceHealth Laboratories' outreach lab services and assume management of labs located within PeaceHealth's medical centers in three states
MADISON, N.J. and VANCOUVER, Wash., Feb. 15, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and PeaceHealth, a mission-based not-for-profit healthcare system, have formed a two-part arrangement to enhance the delivery of laboratory services to communities in Oregon, Wa... |
|02/08/17||Veracyte To Expand Patient Access To The Afirma® Gene Expression Classifier In Thyroid Cancer Diagnosis Through Agreement With Quest Diagnostics|
|SOUTH SAN FRANCISCO, Calif., Feb. 8, 2017 /PRNewswire/ -- Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing unnecessary surgeries and healthcare costs by resolving diagnostic uncertainty, will extend access to its Afirma Gene Expression Classifier (GEC) through an agreement with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services. The agreement is intended to meet growing physician demand for innovative genomic testing ser... |
|01/26/17||Quest Diagnostics Reports Fourth Quarter And Full Year 2016 Financial Results; Provides Guidance For Full Year 2017|
|-- Fourth quarter revenues of $1.86 billion, up 0.7% on a reported basis and up 1.9% on an equivalent basis versus 2015
-- Fourth quarter diluted EPS of $1.09 on a reported basis, down 15.5% from 2015; fourth quarter diluted EPS of $1.31 on an adjusted basis excluding amortization, up 10.1% from 2015
-- Full year revenues of $7.52 billion, up 0.3% on a reported basis and up 2.6% on an equivalent basis versus 2015
-- Full year diluted EPS of $4.51 on a reported basis, down 7.4% from 2015... |
|01/26/17||Quest Diagnostics Partners With Montefiore Health System to Deliver High-Value, Innovative Laboratory Services|
|MADISON, N.J. and NEW YORK, Jan. 26, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, is working with Montefiore Health System (MHS) to provide diagnostic laboratory services. This partnership will enhance the quality and efficiency of laboratory services at Montefiore.
"We are pleased to partner with Montefiore, a premiere academic health system recognized for personalized, accountable car... |
|01/18/17||Quest Diagnostics Launches Nation's First Hepatitis B Virus Quantitative Test to Help Assess Response to Antiviral Therapy|
|Company expands hepatitis testing capabilities with new HBV surface antigen (sAg) quantitative testing
MADISON, N.J., Jan. 18, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the launch of a new test service that helps physicians evaluate a patient's response to drug therapies used to treat infection with the hepatitis B virus (HBV). The first test of its kind available in the United States, the test is sig... |
|01/11/17||Quest Diagnostics To Release Fourth Quarter And Full Year 2016 Financial Results On January 26|
|MADISON, N.J., Jan. 11, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2016 results on Thursday, January 26, 2017, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.
The conference call can be accessed in listen-only mode by diali... |
|01/06/17||Quest Diagnostics Achieves Perfect Score On 2017 Human Rights Campaign Corporate Equality Index|
|MADISON, N.J., Jan. 6, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, received a rating of 100 from the Human Rights Campaign Foundation on the 2017 Corporate Equality Index, earning the distinction of being a "Best Place to Work for LGBT Equality."
The Corporate Equality Index (CEI) is a national benchmarking survey and report on corporate policies and practices related to L... |
|01/05/17||Quest Diagnostics To Speak At The 35th Annual J.P. Morgan Healthcare Conference|
|MADISON, N.J., Jan. 5, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco. Steve Rusckowski, Chairman, President and CEO, will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Wednesday, January 11, 2017 at 5:30 ... |